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Background Signal-averaged ECG is a noninvasive test designed to detect "late potentials." The effects of alterations in autonomic tone on the signal-averaged ECG have not been evaluated systematically.
Methods and Results The effects of autonomic stimulation and blockade on the signal-averaged ECG were evaluated in 14 healthy subjects (8 men and 6 women; age, 28.5 ±4.8 years) on 2 separate days. The signal-averaged ECG was recorded at baseline and after physiological and pharmacologic f3-adrenergic stimulation (tilt, exercise, and epinephrine and isoproterenol infusions), sequential and combined f3-adrenergic and parasympathetic blockade, and a-adrenergic stimulation before and after parasympathetic blockade. Analysis was performed with a bidirectional filter (40-Hz high-pass). Significant changes in the signal-averaged QRS duration from baseline (105.1±+12.0 milliseconds) were noted with tilt T he signal-averaged ECG was initially developed to allow recording of low-amplitude ventricular depolarizations on the surface ECG in patients with myocardial infarctions who are susceptible to ventricular tachycardia.12 These low-amplitude depolarizations, called "late potentials," correspond to delayed and fragmented endocardial or epicardial electrograms3 and are believed to represent a "fixed" substrate for reentrant ventricular tachycardia in these patients. The effects of alterations in autonomic tone on the signalaveraged ECG have not been evaluated systematically in either healthy or diseased populations. Such alterations may be important because autonomic tone is frequently altered in patients to whom the signalaveraged ECG has been applied, such as those who have had a myocardial infarction. 4 Although the signal-averaged ECG was originally developed for use in patients with coronary artery disease and ventricular tachycardia, it has subsequently been applied to a variety of other groups of patients, most notably those with syncope and dilated cardiomyopathy.5-10 It has been proposed to have prognostic significance in these patients, but the pathophysiological basis for this finding has not been explored. Because autonomic tone has also been shown to be an important prognostic factor in some of these subgroups, we postulated that changes in autonomic tone may affect the signal-averaged ECG and perhaps contribute to its prognostic value in patients without coronary artery disease.
To evaluate the potential effects of autonomic tone on the signal-averaged ECG, we initially chose to perform a comprehensive evaluation of autonomic stimulation and blockade on the normal signal-averaged ECG. Although we considered including subjects with myocardial infarctions and late potentials in the present study, we did not believe that we could ethically recruit an adequate number of patients who could undergo the entire protocol.
Methods

Subjects
Fourteen healthy volunteers (8 men and 6 women; age range, 22 to 38 years; mean age, 28.5 +4.8 years) were studied at the Clinical Research Center at Northwestern Memorial Hospital. These subjects were also included in a separate study of the effects of autonomic manipulation on heart rate variability."1 Subjects were instructed to abstain from smoking or coffee consumption for 24 hours before the study. No subject had a history of diabetes mellitus, hypertension, syncope, palpitations, or cardiac disease. All subjects had a normal physical examination, a normal resting ECG, a normal hematocrit, and normal serum electrolytes. No subjects were taking medications. Written, informed consent was obtained before the study. The study was approved by the Northwestern University Institutional Review Board. was obtained in all except 1 subject. After data acquisition, blood for determination of plasma catecholamine levels was again obtained (n=9); subjects were then returned to the supine position, and heart rate and blood pressure were allowed to return to baseline.
Epinephrine infusion. Epinephrine infusion was then begun at a rate of 2 ,g/min with subjects in the supine position and resting comfortably. The dose was gradually increased in all subjects to 50 ng * kg-' minm and maintained at this infusion rate for 10 minutes to achieve steady state. Previous studies have demonstrated that a steady-state concentration is achieved after 10 minutes of infusion.1415 This infusion rate was used because it has been shown to result in elevation of the plasma epinephrine levels similar to that achieved with moderate exercise,'6 hypoglycemia,17 and acute myocardial infarction.18 Five-minute ECG recordings were obtained in triplicate, after which the infusion was stopped; serum potassium levels were determined at the end of the infusion. Potassium levels decreased from a baseline of 4.0+0.3 mEq/L to 3.4±0.4 mEq/L; in the 3 subjects with potassium levels of 3.0 mEq/L or less, repeat determinations after washout of epinephrine demonstrated normalization of the potassium level (4.2±0.3 mEq/L). Heart rate and blood pressure were allowed to return to baseline values.
Isoproterenol infusion. Isoproterenol infusion was then started at a rate of 2 /Lg/min and gradually increased to 50 ng. kg`. min`. This infusion rate was maintained for 10 minutes to achieve steady state because it has been shown19 that at least 90% of the heart rate increase during isoproterenol infusion is achieved by 8 minutes. One subject did not tolerate the maximal dose, and recordings were made at a reduced dose of 25 ng . kg`* min`l. During the infusion, ECG recordings were made in triplicate. The infusion was then stopped, and time was allowed for heart rate and blood pressure to return to baseline values.
Exercise. Subjects then performed symptom-limited exercise on a bicycle ergometer with progressively increasing workloads. Subjects started at a workload of 150 to 300 kilopond (Kp) * m`* min`(corresponding to approximately 25 to 50 W), which was increased by 150 to 300 Kp . m`min`every 2 minutes. All subjects exercised to fatigue (mean exercise time, 8.4±2.4 minutes), achieving a maximal heart rate between 150 and 170 beats per minute (mean, 168±12 beats per minute). They were then returned to bed, and after patients had a 2-minute recovery period, we obtained recordings in triplicate. A rest period was allowed for heart rate and blood pressure to return to baseline values.
Blockade
(-Adrenergic blockade. To achieve P-blockade, we administered propranolol intravenously at a rate of 1 mg/min to a total dose of 0.2 mg/kg with subjects in the supine position.'2 After the infusion was completed, three recordings were obtained.
(-Adrenergic and parasympathetic blockade (double blockade).
Atropine (0.04 mg/kg) was then administered intravenously over 2 minutes in the presence of /3-adrenergic blockade,'2 and three recordings were obtained. Tilt after double blockade. Because of the elapsed time since the initial administration of propranolol, an additional 0.07 mg/kg propranolol was administered as before. Subjects were then tilted to 700 while heart rate and blood pressure were monitored. After 5 minutes of tilt, three ECG recordings were made during tilt. Again, premature termination of the tilt test was required in 4 subjects because of nausea, lightheadedness, or both. However, at least one complete recording was obtained in all except 1 subject. Blood for determination of plasma catecholamine levels was obtained just before tilt and after the final recording, as described previously. Baseline 2
Ten of the 14 subjects returned for the second day of the study (2 were no longer available, 1 had been started on a tricyclic antidepressant, and 1 chose not to continue). Subjects were prepared as on day 1 and allowed to rest comfortably in containing 0.25 pmol epinephrine and 1.6 pmol norepinephrine, intra-assay coefficients of variation were 8% and 1%, respectively, and interassay coefficients of variation were 12%
and 4%, respectively. Data Analysis
The reproducibility of RR intervals at each phase of the study was assessed to determine whether systematic variation related to each intervention was present. Four RR interval measures were made during each of the baseline periods on days 1 and 2; three measures were made for all other conditions. Reproducibility was evaluated by calculating intraclass correlation coefficients using a one-way random-effects ANOVA model.2223 The intraclass correlation coefficient is an assessment of the intrasubject variability of a measure and reflects its reproducibility. An intraclass correlation coefficient of more than 0. 
Results
There were no significant differences among the RR intervals at the two baseline periods (day 1, 980+138 milliseconds; day 2, 1034±109 milliseconds) or after ,p-adrenergic blockade (921±83 milliseconds). ,3-Adrenergic stimulation with tilt, epinephrine infusion, isoproterenol infusion, and exercise resulted in expected significant decreases in the RR intervals to 693±62 milliseconds, 760-118 milliseconds, 489+32 milliseconds, and 637±79 milliseconds, respectively, which is consistent with their f-adrenergic effects. The RR interval also shortened with atropine (542±58 milliseconds), atropine plus propranolol (601±42 milliseconds), tilt with double blockade (617±37 milliseconds), and atropine plus phenylephrine (547±77 milliseconds). Phenylephrine infusion resulted in a significant lengthening of the RR interval to 1355±143 milliseconds, which is consistent with a baroreflex-mediated increase in parasympathetic tone. Mean blood pressure was significantly elevated from baseline during both infusions of phenylephrine and after exercise, whereas no significant changes were noted in mean blood pressure with the other conditions ( Table 1 ). The intraclass correlation coefficients for the RR intervals were excellent (.0.90) at baseline and for all conditions tested except tilt and exercise; thus, for purposes of analysis, the parameters derived from the signal-averaged ECGs for each of these conditions were averaged. The intraclass correlation coefficient using all three RR interval recordings during tilt was 0.72, which was significantly lower than that for the other conditions. However, the intraclass correlation coefficient for the two recordings made at 10 and 15 minutes of tilt was 0.92, indicating two recordings. In contrast, the intraclass correlation coefficient for all three tilt recordings after double blockade was 0.95. Thus, only data from the last two recordings made during tilt (without double blockade) were averaged for analysis. Finally, the intraclass correlation coefficients for the three postexercise period RR intervals also demonstrated less reproducibility (0.67). and therefore each postexercise recording was analyzed separately.
Signal-Averaged ECG
Typical signal-averaged ECGs recorded during each condition are shown in Fig 1. Table 1 summarizes the results for the signal-averaged ECG findings for all conditions tested. Generally, when the QRS duration shortened, the RMS increased, and the LAS decreased. This effect is shown in Fig 2 for norepinephrine levels were 0.93±0.53 and 3.30±2.06 pmol/mL, respectively.
Reproducibility of Signal-Averaged
ECG Parameters
The intraclass correlation coefficient for each signalaveraged ECG parameter is depicted in Table 2 for the multiple 5-minute recordings during each condition. No intraclass correlation coefficients are reported for the postexercise period because it is a time-varying condition that would not be expected to demonstrate a high degree of reproducibility. The intraclass correlation coefficients for the QRS duration and RMS were excellent, ranging from 0.90 to 1.00 for all conditions. For the LAS, the intraclass correlation coefficients were similarly excellent, except during the initial tilt, when it was mildly reduced at 0.73.
Discussion
In this study, we explored the effects of a wide variety of autonomic stimuli on the signal-averaged ECG in a group of healthy subjects. The QRS duration was altered by some of the conditions studied. Upright tilt shortened the QRS duration; of note, during tilt in the presence of double autonomic blockade, a similar shortening in QRS duration was noted. 3-Adrenergic stimulation with isoproterenol also led to a significant shortening of the QRS duration. In contrast, epinephrine prolonged the QRS duration. The effects of the postexercise period on the QRS duration were variable. Increased a-adrenergic stimulation with phenylephrine did not appreciably affect the signal-averaged ECG. Although parasympathetic blockade caused a mild decrease in the QRS duration, parasympathetic stimulation did not significantly affect the QRS duration. Generally, changes in the RMS and LAS paralleled those of the QRS duration. Our findings show that the signal-averaged ECG does not measure only "fixed" parameters. Although the magnitude of the changes in the signal-averaged ECG parameters induced in healthy subjects was statistically significant, further work is necessary to investigate whether alterations in autonomic tone in patients with heart disease produce clinically important changes in these parameters.
The signal-averaged ECG has been a useful noninvasive test for risk stratification of patients after a myocardial infarction. Because the relative intensity of f3-adrenergic stimulation achieved with each of the four conditions differed, it is possible that the QRS duration may have a bimodal response to 13-adrenergic stimulation. Furthermore, differences in the relative amounts of /-adrenergic, a-adrenergic, and parasympathetic stimulation may have altered the results. However, the difference in the effects of epinephrine and isoproterenol on the QRS duration are not likely to be related to the a-adrenergic effects of epinephrine as phenylephrine infusion after atropine had no significant effect on the QRS duration (in fact, the trend was to shorten the QRS duration). Similarly, differences in parasympathetic tone appear unlikely to explain the observed differences as tilt has been associated with parasympathetic withdrawal36 and isoproterenol has been associated with increased parasympathetic tone37; both of these conditions decreased the QRS duration. Furthermore, parasympathetic blockade decreased the QRS duration, but parasympathetic stimulation had no effect on the QRS duration. Finally, the QRS duration prolongation with epinephrine infusion is not likely to be related to the mild hypokalemia associated with epinephrine infusion as even severe hypokalemia in dogs has been shown to have little effect on the QRS duration.38
The shortening of the QRS duration with tilt after autonomic blockade provides an additional hypothesis. It suggests that the tilt-induced changes in QRS duration 
Study Limitations
The major limitation of the present study is the absence of patients with late potentials. Although we considered including patients with heart disease in this study, we did not believe that we could ethically include a sufficient sample of such patients who could undergo the entire protocol. Thus, rather than limit the scope of the study, we chose to perform a comprehensive evaluation of the effects of autonomic stimulation and blockade in subjects who could tolerate the entire study. As the data demonstrate that autonomic tone can affect the normal signal-averaged ECG, further studies are required to evaluate the effects of autonomic tone on the signal-averaged ECG in patients with heart disease.
Many conditions were tested in this study over a 2-day period. The order of testing was specifically chosen so that the testing could be completed within a 2-day period with a return to baseline heart rate and blood pressure between conditions. Although it is possible that there was a cumulative effect from the various conditions, the magnitude of such an effect is likely very small as testing for each condition was only begun when the subject's heart rate and blood pressure returned to baseline values. Day 1 studies typically lasted 5 to 7 hours to allow for this. Furthermore, as expected, none of the parameters recorded during 3-adrenergic blockade with subjects in the supine position, which was performed at the end of the day, were significantly different from baseline parameters acquired at the beginning of the day. An additional limitation is that noise levels obtained during the signal-averaged ECG recordings varied among the conditions tested, which may affect the QRS duration determinations.49 However, the magnitude of the alterations in QRS duration observed in the present study were greater than the expected changes attributable to differences in noise levels,49 suggesting that our results do not reflect changes in noise levels with the differing conditions. Clinical Implications
Our data suggest that the signal-averaged ECG does not measure 'fixed' parameters as the results were altered by the tested conditions. The signal-averaged ECG has been most extensively evaluated in patients with myocardial infarctions. In this population, the finding of a 'late potential' has been presumed to be fixed. Similarly, the prognostic value of the signalaveraged ECG in patients with dilated cardiomyopathy5 has been presumed to be related to the detection of some fixed substrate. Further studies are necessary in these patient populations to evaluate the effects of autonomic tone (and perhaps other factors) on the signal-averaged ECG and to define how these factors may influence the prognostic usefulness of this test.
